[go: up one dir, main page]

ES2144888T3 - 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc. - Google Patents

4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc.

Info

Publication number
ES2144888T3
ES2144888T3 ES98300249T ES98300249T ES2144888T3 ES 2144888 T3 ES2144888 T3 ES 2144888T3 ES 98300249 T ES98300249 T ES 98300249T ES 98300249 T ES98300249 T ES 98300249T ES 2144888 T3 ES2144888 T3 ES 2144888T3
Authority
ES
Spain
Prior art keywords
treatment
tetrahidropiridina
indol
fluorine
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98300249T
Other languages
English (en)
Inventor
John Fairhurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co Ltd
Eli Lilly and Co
Original Assignee
Eli Lilly and Co Ltd
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co Ltd, Eli Lilly and Co filed Critical Eli Lilly and Co Ltd
Application granted granted Critical
Publication of ES2144888T3 publication Critical patent/ES2144888T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN COMPUESTO FARMACEUTICO DE FORMULA EN LA CUAL R 1 ES HIDROGENO, ALQUILO C 1-4 , ALCOXI C 1-4 O HALOGENO Y R 2 ES HIDROGENO, ALQUILO C 14 , ALCOXI C 1-4 O UNA SAL DEL MISMO. LOS COMPUESTOS DE LA INVENCION Y SUS SALES FARMACEUTICAMENTE ACEPTABLES ESTAN INDICADAS PARA SU USO EN EL TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL.
ES98300249T 1997-01-17 1998-01-14 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc. Expired - Lifetime ES2144888T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700895.7A GB9700895D0 (en) 1997-01-17 1997-01-17 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ES2144888T3 true ES2144888T3 (es) 2000-06-16

Family

ID=10806121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98300249T Expired - Lifetime ES2144888T3 (es) 1997-01-17 1998-01-14 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc.

Country Status (29)

Country Link
US (1) US20010053783A1 (es)
EP (1) EP0854146B1 (es)
JP (1) JPH10204090A (es)
KR (1) KR20000070221A (es)
AR (1) AR011422A1 (es)
AT (1) ATE190617T1 (es)
AU (1) AU5569298A (es)
CA (1) CA2227132A1 (es)
CZ (1) CZ290318B6 (es)
DE (1) DE69800092T2 (es)
DK (1) DK0854146T3 (es)
EA (1) EA001469B1 (es)
ES (1) ES2144888T3 (es)
GB (1) GB9700895D0 (es)
GR (1) GR3033316T3 (es)
HU (1) HUP0000854A3 (es)
ID (1) ID21920A (es)
IL (1) IL129647A (es)
NO (1) NO993372L (es)
NZ (1) NZ335493A (es)
PE (1) PE99399A1 (es)
PL (1) PL334569A1 (es)
PT (1) PT854146E (es)
SI (1) SI0854146T1 (es)
SV (1) SV1998000088A (es)
TR (1) TR199901583T2 (es)
TW (1) TW396156B (es)
WO (1) WO1998031686A1 (es)
ZA (1) ZA98300B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
GB9825413D0 (en) 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9903784D0 (en) * 1999-02-18 1999-04-14 Lilly Co Eli Pharmaceutical compounds
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
KR101165996B1 (ko) 2010-04-23 2012-07-18 주식회사 녹십자 프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
CN105949190B (zh) * 2016-07-04 2018-06-29 烟台凯博医药科技有限公司 一种制备1,8-萘啶及衍生物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems

Also Published As

Publication number Publication date
PT854146E (pt) 2000-08-31
PL334569A1 (en) 2000-03-13
ATE190617T1 (de) 2000-04-15
AU5569298A (en) 1998-08-07
EA001469B1 (ru) 2001-04-23
CZ290318B6 (cs) 2002-07-17
NO993372D0 (no) 1999-07-08
EP0854146B1 (en) 2000-03-15
ID21920A (id) 1999-08-12
HUP0000854A2 (hu) 2000-11-28
EA199900667A1 (ru) 2000-02-28
SI0854146T1 (en) 2000-10-31
EP0854146A1 (en) 1998-07-22
US20010053783A1 (en) 2001-12-20
ZA98300B (en) 1998-09-10
NO993372L (no) 1999-07-08
DE69800092T2 (de) 2000-09-14
HUP0000854A3 (en) 2002-06-28
PE99399A1 (es) 1999-11-11
SV1998000088A (es) 2000-10-10
DK0854146T3 (da) 2000-06-05
IL129647A0 (en) 2000-02-29
WO1998031686A1 (en) 1998-07-23
DE69800092D1 (de) 2000-04-20
TW396156B (en) 2000-07-01
GR3033316T3 (en) 2000-09-29
AR011422A1 (es) 2000-08-16
CZ151099A3 (cs) 1999-09-15
TR199901583T2 (xx) 1999-11-22
KR20000070221A (ko) 2000-11-25
JPH10204090A (ja) 1998-08-04
GB9700895D0 (en) 1997-03-05
IL129647A (en) 2002-02-10
NZ335493A (en) 2000-09-29
CA2227132A1 (en) 1998-07-17

Similar Documents

Publication Publication Date Title
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
PA8436201A1 (es) Derivados 6,5-heterobiciclicos sustituidos
ES2072627T3 (es) Derivados de piridina y n-oxido de piridina de diarilmetilpiperidinas o piperazinas, composiciones y uso de las mismas.
ES2121896T3 (es) Derivados de acido hidroxamico como inhibidores de colagenasa.
HN2002000028A (es) Pirimidinas inhibidoras de metaloproteinasas
PA8431301A1 (es) Inhibidores de metaloproteinasas, composiciones farmaceuticas que los contienen y sus usos farmaceuticos y los metodos e intermedios utiles para su preparacion
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
CO5690131A1 (es) Derivados de eter biarilico que presentan actividad como inhibidores de la recaptacion de monoaminas para el tratamiento de transtornos del snc
AR028810A1 (es) Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion
DE60119397D1 (de) "2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
CY1106560T1 (el) Ανταγωνιστες υποδοχεα αδενοσινης και μεθοδοι κατασκευης και χρησης αυτων
AR030507A1 (es) Compuesto de pirazolopiridina y los usos farmaceuticos del mismo
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
ES2150039T3 (es) Benzonitrilos como 5-ht agonistas y antagonistas.
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR029343A1 (es) USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN
TR200001452T2 (tr) Bifenilamidin türevleri.
ES2144888T3 (es) 4-(6-fluoro-(1h)-indol-3-il)-1,2,3,6-tetrahidropiridina sustituida para el tratamiento de desordenes del snc.
ATE302776T1 (de) Kondensierte pyridoindolderivate
MX9204342A (es) Indoles.
AR029588A1 (es) Nueva forma (r)-n-[5-metil-8-(4-metilpiperazina-1-il)-1,2,3,4-tetrahidro-2-naftil]-4-morfolinobenzamida
ES2111492B1 (es) Derivados de 1-(2-(vinilo substituido))-3,4-dihidro-5h-2,3-benzodiazepina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y utilizacion de dichos derivados y composiciones para el tratamiento de trastornos del sistema nervioso central.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 854146

Country of ref document: ES